Showing results (911-920 of 979) with videos related to
Sort By:
Pageof 98
The World Allergy Organization Journal|November 12, 2019
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testingS Zielen, P Kuna, W Aberer, et al.Cancer Research|January 13, 2011
Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progressionSanjib Banerjee, Chuen-Fu L Lin, Kristin A Skinner, et al.The Journal of Allergy and Clinical Immunology|December 24, 2019
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergensFederico Storni, Andris Zeltins, Ina Balke, et al.Allergy|February 5, 2025
Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well-Tolerated in a Pivotal Phase III TrialStefan Zielen, Jonathan A Bernstein, Gunter J Sturm, et al.American Journal of Medical Genetics. Part A|November 10, 2020
Phenotypic features in MECP2 duplication syndrome: Effects of ageSarika U Peters, Cary Fu, Eric D Marsh, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 12, 2018
The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2Jeffrey L Neul, Timothy A Benke, Eric D Marsh, et al.Vaccine|July 18, 2006
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian menE B Imoukhuede, T Berthoud, P Milligan, et al.Human Molecular Genetics|December 2, 2022
Clinical and functional characterization of germline PIK3CA variants in patients with PIK3CA-related overgrowth spectrum disordersJessica A Cooley Coleman, Jennifer M Gass, Sujata Srikanth, et al.Journal of Developmental and Behavioral Pediatrics : JDBP|August 24, 2010
A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlationsJennifer K Gentile, Wen-Hann Tan, Lucia T Horowitz, et al.Proceedings of the National Academy of Sciences of the United States of America|March 23, 2005
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus AnkaraDaniel P Webster, Susanna Dunachie, Jenni M Vuola, et al.Pageof 98